New strategy of platelet substitutes for enhancing platelet aggregation at high shear rates: cooperative effects of a mixed system of fibrinogen γ-chain dodecapeptide- or glycoprotein Ibα-conjugated latex beads under flow conditions

To construct platelet substitutes that have hemostatic properties over a wide range of shear rates, we used fibrinogen γ-chain carboxy-terminal sequence HHLGGAKQAGDV (H12), which recognizes activated platelets at low shear rates, and a recombinant water-soluble moiety of the platelet glycoprotein (rGPIbα), which recognizes von Willebrand factor at high shear rates. Three kinds of samples were prepared for this purpose: H12-conjugated latex beads (H12-latex beads), rGPIbα-latex beads, and H12/rGPIbα-latex beads. These samples were evaluated in thrombocytopenia-imitation blood at various flow conditions. Based on ADP-induced platelet aggregation studies, the H12-latex beads significantly enhanced platelet aggregation via H12 binding with GPIIb/IIIa activated on the surface of activated platelets, whereas the rGPIbα-latex beads did not support platelet aggregation. In the case of the H12/rGPIbα-latex beads, the function of H12 was suppressed by steric hindrance from the larger rGPIbα bound to the latex bead. A mixture of the H12-latex beads and the rGPIbα-latex beads adhered to a collagen surface over a wide range of shear rates. In particular, at high shear rates, a cooperative effect was observed in the enhancement of platelet thrombus formation compared with H12-latex beads or rGPIbα-latex beads alone. We propose that a mixed system of H12- and rGPIbα-conjugated nanoparticles is a more effective platelet substitute than each of the beads used alone and has enhanced platelet aggregation properties.

[1]  D. Hallahan,et al.  Targeting drug delivery to radiation-induced neoantigens in tumor microvasculature. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[2]  J. Levin,et al.  Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits , 1999, Nature Medicine.

[3]  J. Sixma,et al.  Functional self-association of von Willebrand factor during platelet adhesion under flow , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Y. Teramura,et al.  Rolling properties of rGPIBα-conjugated phospholipid vesicles with different membrane flexibilities on vWf surface under flow conditions , 2002 .

[5]  C. Legrand,et al.  Efficiency of platelet adhesion to fibrinogen depends on both cell activation and flow. , 2000, Biophysical journal.

[6]  M. Murata,et al.  Targeting of liposomes carrying recombinant fragments of platelet membrane glycoprotein Ibalpha to immobilized von Willebrand factor under flow conditions. , 2000, Biochemical and biophysical research communications.

[7]  D. F. Young,et al.  Flow through a converging-diverging tube and its implications in occlusive vascular disease. I. Theoretical development. , 1970, Journal of biomechanics.

[8]  A. Yoda,et al.  Two different phosphorylation-dephosphorylation cycles of Na,K-ATPase proteoliposomes accompanying Na+ transport in the absence of K+. , 1987, The Journal of biological chemistry.

[9]  J. Miller,et al.  Infusible platelet membranes retain partial functionality of the platelet GPIb/IX/V receptor complex. , 2001, American journal of clinical pathology.

[10]  K Watanabe,et al.  The role of von Willebrand factor and fibrinogen in platelet aggregation under varying shear stress. , 1991, The Journal of clinical investigation.

[11]  Eishun Tsuchida,et al.  Hemostatic effects of polymerized albumin particles bearing rGPIa/IIa in thrombocytopenic mice. , 2003, Biochemical and biophysical research communications.

[12]  Y. Teramura,et al.  Conjugation of von Willebrand factor-binding domain of platelet glycoprotein Ib alpha to size-controlled albumin microspheres. , 2000, Biomacromolecules.

[13]  J. Ware,et al.  Adhesive properties of the isolated amino-terminal domain of platelet glycoprotein Ibalpha in a flow field. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[14]  S. Lam,et al.  Evidence that arginyl-glycyl-aspartate peptides and fibrinogen gamma chain peptides share a common binding site on platelets. , 1987, The Journal of biological chemistry.

[15]  T. Pestina,et al.  The roles of ADP and TXA2 in botrocetin/VWF‐induced aggregation of washed platelets , 2004, Journal of thrombosis and haemostasis : JTH.

[16]  J S Lee,et al.  Flow in nonuniform small blood vessels. , 1971, Microvascular research.

[17]  B. Coller,et al.  Thromboerythrocytes. In vitro studies of a potential autologous, semi-artificial alternative to platelet transfusions. , 1992, Journal of Clinical Investigation.

[18]  Y. Teramura,et al.  Fibrinogen-conjugated albumin polymers and their interaction with platelets under flow conditions. , 2001, Biomacromolecules.

[19]  Yuji Teramura,et al.  Hemostatic effects of phospholipid vesicles carrying fibrinogen gamma chain dodecapeptide in vitro and in vivo. , 2005, Bioconjugate chemistry.

[20]  M. Rybak,et al.  A liposome based platelet substitute, the plateletsome, with hemostatic efficacy. , 1993, Biomaterials, artificial cells, and immobilization biotechnology : official journal of the International Society for Artificial Cells and Immobilization Biotechnology.

[21]  G. Agam,et al.  Erythrocytes with covalently bound fibrinogen as a cellular replacement for the treatment of thrombocytopenia , 1992, European journal of clinical investigation.

[22]  J. Ware,et al.  Site-directed mutagenesis of a soluble recombinant fragment of platelet glycoprotein Ib alpha demonstrating negatively charged residues involved in von Willebrand factor binding. , 1991, The Journal of biological chemistry.

[23]  R. Marchant,et al.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor. , 1996, Blood.

[24]  M. Murata,et al.  Characterization of liposomes carrying von Willebrand factor-binding domain of platelet glycoprotein Ibalpha: a potential substitute for platelet transfusion. , 1999, Biochemical and biophysical research communications.

[25]  S. Timmons,et al.  Platelet receptor recognition site on human fibrinogen. Synthesis and structure-function relationship of peptides corresponding to the carboxy-terminal segment of the gamma chain. , 1984, Biochemistry.

[26]  M. Bednarek,et al.  Platelet receptor recognition domain on the gamma chain of human fibrinogen and its synthetic peptide analogues. , 1989, Biochemistry.

[27]  S. Timmons,et al.  Localization of a site interacting with human platelet receptor on carboxy-terminal segment of human fibrinogen gamma chain. , 1982, Biochemical and biophysical research communications.

[28]  Y. Teramura,et al.  Function of fibrinogen γ-chain dodecapeptide-conjugated latex beads under flow , 2003 .

[29]  Y. Teramura,et al.  Hemostatic effects of fibrinogen γ‐chain dodecapeptide‐conjugated polymerized albumin particles in vitro and in vivo , 2005, Transfusion.

[30]  Z. Ruggeri.  Structure of von Willebrand factor and its function in platelet adhesion and thrombus formation. , 2001, Best practice & research. Clinical haematology.

[31]  M. Murata,et al.  Reconstitution of adhesive properties of human platelets in liposomes carrying both recombinant glycoproteins Ia/IIa and Ib alpha under flow conditions: specific synergy of receptor-ligand interactions. , 2002, Blood.